Sunday, January 12, 2020

Lupin issued two 483 observations by USFDA at Nagpur oral solid dosage manufacturing facility

The inspection was carried out between January 6, 2020 and January 10, 2020.

from India Infoline News Service https://ift.tt/2tbDrRB
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)